Articles tagged with: Top Research
News»

The year 2013 is likely to be remembered as a very good year when it comes to research related to multiple myeloma.
Previous years have witnessed research shedding new light on existing myeloma therapies, as well as additional research about potential new therapies.
But, in the past, most of the important new therapies that were being researched were from existing classes of therapy, making them less likely to offer dramatic improvements in the treatment of the disease.
In 2013, not only was there more research about existing therapies, and more research about …
News, Opinion»

Last year, 2013, was a great year for myeloma research.
We had a number of important discoveries that will impact diagnosis, monitoring, prognosis, and treatment of the disease. Some new findings provide us with a better understanding of myeloma biology and mechanisms of drug resistance, while others present information that immediately impacts how patients are managed.
Collectively, these discoveries represent a significant advance towards our goal of curing myeloma.
I present here my list of the top 10 most compelling scientific findings and discoveries of 2013 in the field of multiple myeloma. …
News»

Looking back at all that has happened in the world of multiple myeloma since January of 2012, it is hard not to be impressed by the many important developments that took place.
There is the obvious fact that, during that time, not one, but two new drugs to treat myeloma were approved by the U.S. Food and Drug Administration (FDA). Prior to 2012, the FDA had not approved a novel anti-myeloma therapy in over six years.
Yet 2012 was meaningful to the myeloma community for reasons beyond the activity at the FDA’s …
News»

Many new and promising research developments occurred in the field of multiple myeloma during 2011. Over the course of the year, The Myeloma Beacon published nearly 100 articles on important myeloma-related studies.
To identify the most important of these studies from 2011, The Myeloma Beacon surveyed leading physicians and researchers in the field. They were asked to name the three peer-reviewed journal articles published in 2011 and the three conference presentations from 2011 that have the most important findings or implications relating to multiple myeloma.
Their selections for the most important journal …
News»

Many new and promising research developments were made in the field of multiple myeloma during 2010. Over the course of the year, The Myeloma Beacon published more than 100 articles on important myeloma-related studies.
To highlight the most important of these studies from 2010, The Myeloma Beacon surveyed leading physicians and researchers in the field. They were asked to name the three peer-reviewed journal articles published in 2010 and the three conference presentations from 2010 that have the most important findings or implications relating to multiple myeloma.
Their selections for the …
News»

The year 2009 brought a lot of new and exciting advancements in the field of multiple myeloma. Over the course of 2009, The Myeloma Beacon covered more than 100 important myeloma-related studies.
To highlight the most important of these studies, the Myeloma Beacon surveyed leading physicians and researchers in the field. These physicians and researchers were asked to name the three peer reviewed journal articles published in 2009 and the three conference abstracts from 2009 that have the most important findings or implications relating to multiple myeloma.
The top three journal …